Peer-reviewed veterinary case report
Using tepoxalin and meloxicam for treating cats - effects and safety
By Charlton, Anna N et al.Ā·Published in Journal of feline medicine and surgeryĀ·2013Ā·College of Veterinary Medicine, United StatesĀ·View original on PubMed ā
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research ā every detail traces back to the citation above. How we work ā
Original publication title: Evaluation of the clinical use of tepoxalin and meloxicam in cats.
- Species:
- cat
Plain-English summary
A review of medical records found that tepoxalin (Zubrin) and meloxicam (Metacam) were both safely used in cats for pain relief. The study included 79 cats, with tepoxalin given for an average of 11 days and meloxicam for about 93 days. Some cats experienced mild side effects, but most had normal blood test results after treatment. Overall, both medications were well tolerated, suggesting they can be effective options for managing pain in cats.
People also search for: cat pain relief medication Ā· tepoxalin for cats Ā· meloxicam side effects in cats
Abstract
Medical records where tepoxalin (Zubrin) or meloxicam (Metacam) were prescribed in cats were reviewed and data extracted. Comparisons were performed for exploring changes between pre- and post-non-steroidal anti-inflammatory drug course laboratory tests. Seventy-nine medical records fit the inclusion criteria (n = 57 and n = 22, tepoxalin and meloxicam, respectively). The median dosages administered were 13 and 0.029 mg/kg(/)day (tepoxalin and meloxicam, respectively). Median prescription durations were 11 (2-919) and 93 (4-1814) days for tepoxalin and meloxicam, respectively. Suspected adverse events were reported for tepoxalin (9%, 5/57 cats) and meloxicam (18%, 4/22 cats) a median of 774 and 448 days, respectively, after the prescription started. For cats prescribed meloxicam, there were several statistically significant changes for serum biochemistry and hematology parameters, but median values were within normal limits. These valuable clinical data suggest that tepoxalin and meloxicam are well tolerated in the clinical setting at the doses prescribed in this study.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases āOriginal publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23349526/